Biohaven Pharma (BHVN) Reports Q2, Provides Update on Recent Business Developments
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St rises as AI momentum holds heading into key earnings, Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| (NYSE: BHVN) | Delayed: 14.96 +0.51 (3.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.45 | 52 Week High | $ | |||
| Open | $14.44 | 52 Week Low | $ | |||
| Day High | $15.15 | P/E | N/A | |||
| Day Low | $14.13 | EPS | $ | |||
| Volume | 819,756 | |||||
| (NASDAQ: PRTG) | Delayed: 6.81 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.81 | 52 Week High | $ | |||
| Open | $6.81 | 52 Week Low | $ | |||
| Day High | $6.81 | P/E | N/A | |||
| Day Low | $6.81 | EPS | $ | |||
| Volume | 45,296 | |||||
